The plant in Kabul, Afghanistan, is proving to be a crucial factor in the worldwide supply market for Abacavir Sulphate drug substance. This regional manufacturing capacity represents a substantial step forward for the Afghan pharmaceutical industry and offers a special opportunity to lower requirement on overseas providers. The generation of this